Glyburide Should Not Be First-Line for Gestational Diabetes Glyburide Should Not Be First-Line for Gestational Diabetes

Noninferiority study suggests glyburide may be associated with up to a 10.5% increase in perinatal complications compared with insulin treatment of gestational diabetes.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news